Although research on the ACOD1 protein is still in its early stages, further understanding of the ACOD1/itaconate pathway in neurodegeneration might identify a new molecular target for inhibiting neuroinflammation, a common characteristic of neurodegenerative diseases such as AD and PD. The gene discussed is ACOD1; the disease is Parkinson disease.